We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Investigation |

Efficacy of Coblation Endoscopic Lingual Lightening in Multilevel Surgery for Obstructive Sleep Apnea

Hsueh-Yu Li, MD1,2; Li-Ang Lee, MD1; Eric J. Kezirian, MD, MPH3
[+] Author Affiliations
1Sleep Center, Department of Otorhinolaryngology–Head and Neck Surgery, Linkou-Chang Gung Memorial Hospital, Chang Gung University, Taoyuan, Taiwan, Republic of China
2Department of Sleep Medicine, Royal Infirmary Edinburgh, Edinburgh, Scotland
3USC Tina and Rick Caruso Department of Otolaryngology–Head and Neck Surgery, Keck School of Medicine of USC, University of Southern California, Los Angeles
JAMA Otolaryngol Head Neck Surg. 2016;142(5):438-443. doi:10.1001/jamaoto.2015.3859.
Text Size: A A A
Published online

Importance  Multilevel obstruction is involved in the pathogenesis of obstructive sleep apnea (OSA). Coblation endoscopic lingual lightening (CELL) is a variation of glossectomy to reduce tongue collapse and can be considered in the surgical management of adults with OSA.

Objective  To evaluate the clinical and polysomnographic outcomes of tongue base reduction using CELL in multilevel surgery for OSA.

Design, Setting, and Participants  A retrospective case-control study was performed to review the medical records of adults with OSA (apnea-hypopnea index [AHI], >20) and Friedman stage III (tongue position III and tonsil size I-II) who underwent combined CELL and relocation pharyngoplasty (group 1) or relocation pharyngoplasty alone (group 2) for OSA between January 1, 2012, and December 31, 2013, at a tertiary referral sleep center. The groups were matched by age, sex, body mass index, and AHI at baseline. The dates of the analysis were May 30 to June 29, 2014.

Intervention  Coblation endoscopic lingual lightening.

Main Outcomes and Measures Methods  The primary outcome measure was change in AHI after surgery (after ≥6 months). Other outcomes were differences in surgical response rates, perioperative apnea index, lowest oxygen saturation, and Epworth Sleepiness Scale score.

Results  The study cohort comprised 90 participants. Their mean (SD) age was 40.7 (9.2) years, and 96% (86 of 90) were male. Group 1 patients (n = 30) underwent combined CELL and relocation pharyngoplasty, and group 2 patients (n = 60) underwent relocation pharyngoplasty only. The mean (SD) AHI decreased from 48.4 (16.9) to 16.5 (11.2) (P < .001) in group 1 and from 44.2 (19.3) to 20.1 (15.6) (P < .001) in group 2 . Percentage change in AHI was significantly different between group 1 and group 2 (mean [SD], −65.5 [20.5] vs −53.2 [30.3]) (P = .047). The surgical response rate was greater in group 1 (73% [22 of 30]) than in group 2 (50% [30 of 60]) (P = .04).

Conclusions and Relevance  Without increasing complications, combined CELL and relocation pharyngoplasty achieved greater AHI reduction and a higher surgical response rate among adults with OSA and Friedman stage III compared with relocation pharyngoplasty alone.

Figures in this Article


Place holder to copy figure label and caption
Figure 1.
A Scenario of Coblation Endoscopic Lingual Lightening (CELL)

A, The surgeon is shown performing CELL using videoendoscopic guidance (modified from Li et al13 with permission). B and C, CELL involves submucosal debulking of the tongue body (B) and open ablation of the tongue base (C).

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.
Comparison of Change in Apnea-Hypopnea Index (AHI) Between the 2 Groups Before and After Surgery

The AHI reduction in group 1 (combined coblation endoscopic lingual lightening and relocation pharyngoplasty) was significantly higher than that in group 2 (relocation pharyngoplasty only). The mean (95% CIs) are shown.

aP < .05.

Graphic Jump Location




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles